⌕
MeiraGTx Holdings · MGTX · Nasdaq
Tenet 63 · Solid
Compare
$8.74−4.79%At closeTenet 63 · Solid
$8.74−0.44 (−4.79%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD

MeiraGTx Holdings (MGTX) Key Ratios

Valuation, quality, health and growth. Every ratio ranked against its sector peers — the number we score — with its own ten-year record shown beside it for context.

Sources Company filings and market prices Filings and pricesRatios computed How we compute thisNot investment advice
78
VALUE
Low multiples vs sector
discount to its peers
66
QUALITY
Decent
mid-pack profitability
53
HEALTH
Stable
manageable balance sheet
53
GROWTH
FCF only
growth rates not measurable; scored on FCF margin alone

A decent business at low multiples for its sector: value 78, quality 66, health 53, growth 53, each a percentile within Healthcare.

Values are the trailing twelve months where a company files quarterly statements and the figure passes our check against the filings, with balance-sheet ratios from the most recent quarter; otherwise, or where a sector's figure is still under review, the latest fiscal year. Piotroski and the five-year growth rates are fiscal years. Each row names its period.track = where peers land, worse → better (direction-adjusted: right always means better)▏sector median● you are here▲ where today's value sits in the company's own ten fiscal years (context, not scored)hover any metric for its formula
78th pctilediscount to its peers
Earnings yield (EBIT/EV)Trailing twelve months: EBIT (operating income) summed over the four most recent quarters ÷ enterprise value on the current market cap, with debt, preferred stock, minority interest, cash and short-term investments from the most recent quarter's balance sheet (Greenblatt). The vendor's own earnings yield is net income to common ÷ market cap, a different figure.21.6%97th pctileown record too shortEBIT, TTM through Sep 30, 2026 ÷ enterprise value at the close of Nov 13, 2026
P/E11.987th pctileown record too shortPrice at the close of Nov 13, 2026 ÷ the vendor's trailing-twelve-month EPSThe vendor's trailing twelve months: trailing figures for Healthcare are still under review
P/B4.250th pctileMarket cap at the close of Nov 13, 2026 ÷ book equity at Sep 30, 2026 (most recent quarter)
P/FCF—Not meaningful: the denominator is zero or negative.
EV / EBITDA—Not meaningful: EBITDA is zero or negative.
53rd pctilemanageable balance sheet
Current ratio4.6263rd pctileMost recent quarter, Sep 30, 2026
Quick ratioMost recent quarter: (Cash, short-term investments and receivables) ÷ current liabilities on the most recent quarter's balance sheet, as the data vendor builds it for that quarter. Its receivables include non-trade receivables, which Tenet's balance sheet shows inside other current assets.3.9763rd pctileMost recent quarter, Sep 30, 2026
Net debt / EBITDA(Total debt − cash) ÷ EBITDA—Not meaningful: EBITDA is zero or negative.
Interest coverage—Not meaningful: operating income is zero or negative.
Debt / equity0.5733rd pctileMost recent quarter, Sep 30, 2026
66th pctilemid-pack profitability
ROIC53%99th pctileown record too shortTTM through Sep 30, 2026
ROE215%99th pctileTTM through Sep 30, 2026
Gross margin—Withheld: cost of revenue is not on file, so the gross margin is not measured.
Net margin46.1%98th pctileown record too shortTTM through Sep 30, 2026
Income quality (CFO/NI)0.01×7th pctileown record too shortTTM through Sep 30, 2026
Piotroski F4 / 943rd pctileown record too shortFiscal 2025 (Dec 31, 2025)
Altman Z3.252nd pctileTTM through Sep 30, 2026
53rd pctilegrowth rates not measurable; scored on FCF margin alone
Revenue CAGRThe yearly rate that compounds the earliest fiscal year's revenue into the latest one, over the true number of fiscal years between them (up to five). When the earliest year's revenue is zero or negative, the rate starts from the first later year with at least $10M of revenue, provided at least three years remain.—This growth figure starts in a period outside the history your plan includes.
EPS CAGR—This growth figure starts in a period outside the history your plan includes.
FCF margin−61.7%24th pctileown record too shortFiscal 2025 (Dec 31, 2025)Fiscal 2025: trailing figures for Healthcare are still under review
the receipts behind the numbers above
Greenblatt earnings yield21.6%EBIT ÷ EV The vendor's "earningsYield" is NI ÷ market cap, which is not Greenblatt's formula.
ROIC53%NOPAT ÷ invested capital The vendor's simple ROIC, not its tiny-base roic tag; withheld when a negative EBIT flips its sign.
Interest coverage— Guarded, not faked: we have no interest-expense figure on file for this company, so it's excluded from the ranking instead of rendered as garbage.
Percentiles computed nightly against 409 Healthcare peers from our ingested fundamentals DB · raw statements for corrected metrics. Direction-adjusted: for "lower is better" ratios (P/E, D/E…) the percentile is flipped so right always means better. The percentile is the stock's rank among sector peers, the number that is scored. The triangle marks where the current value (the trailing twelve months or the latest fiscal year, as its row names) sits in the company's own ten fiscal-year record, shown for context and never blended into the score. Computed Nov 16, 2026 · Not investment advice.

What is MeiraGTx Holdings' P/E ratio?

MeiraGTx Holdings' P/E is 11.9 on trailing twelve-month earnings at the Nov 13, 2026 close.

What is MeiraGTx Holdings' Piotroski F-Score?

MeiraGTx Holdings' Piotroski F-Score is 4 of 9 for fiscal 2025.

What is MeiraGTx Holdings' Altman Z-Score?

MeiraGTx Holdings' Altman Z-Score is 3.2, TTM through Sep 30, 2026.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.